Settore biotecnologico: dal vaccino contro il cancro al COVID-19
TAKIS S.r.l. – Tecnopolo
Home
Bonus episode: The virus hunter
Un vaccino italiano. Daniela Mecenate intervista Luigi Aurisicchio, AD di Takis Biotech | 15-02-2021 | Zapping Radio 1 | Rai Radio 1 Sport | RaiPlay Sound
Takis Biotech Interview - Italy Life Sciences 2021
Federazione SPERA, le ragioni della ricerca
Applied DNA and Takis Biotech partner on coronavirus vaccine
Covid: via libera dell'Agenzia del farmaco ai test sul vaccino Takis-Rottapharm Biotech - Il Cittadino di Monza e Brianza
Takis – società biotech in campo contro il coronavirus – Tecnopolo
Will COVID-19 spark a cancer vaccine boom? - EIT Health
Omicron, al via test preclinici per il vaccino anti-varianti di Takis-Rottapharm Biotech - AboutPharma
News
Takis Biotech starting preclinical experimentation with COVID-19 vaccine
Home
Vaccino Covid, Luigi Aurisicchio (Takis Biotech): "La politica non ci sta aiutando"
News
Applied DNA, Takis Biotech partner on coronavirus vaccine - Applied DNA Sciences
Together for Healthier Lives in Europe
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models: Molecular Therapy
Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNAT Vaccine Candidates Designed
Macroarea di Scienze MM.FF.NN. » Seminari e Congressi
Partita la sperimentazione del vaccino italiano Takis - Biotech - ANSA.it
I nostri Partner | IGEA Medical
Italian Biotech Company Takis Announce the Production of Antibodies Against SARS-CV-2 - Leaders League
Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed - Applied DNA Sciences
Rottapharm Biotech and Takis enter an agreement for the co-development of the vaccine against COVID-19 - Rottapharm Biotech
